Olmutinib
Olmutinib
Olmutinib (pronounced ol-mu-ti-nib) is a medicinal drug used in the treatment of lung cancer. It is specifically designed for patients with a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body and has not responded to other treatments.
Etymology
The name "Olmutinib" is derived from the pharmaceutical company's name, Olmu, and the suffix -tinib, which is commonly used for tyrosine kinase inhibitors, a class of drugs that Olmutinib belongs to.
Usage
Olmutinib is used to treat patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), who have progressed on or after EGFR TKI therapy.
Mechanism of Action
Olmutinib works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply. This is done by inhibiting the EGFR T790M mutation, which is often responsible for the development and progression of non-small cell lung cancer.
Related Terms
See Also
External links
- Medical encyclopedia article on Olmutinib
- Wikipedia's article - Olmutinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski